EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition

Document Details

Document Type
Pub Defense Publication
Publication Date
Feb 01, 2020
Source ID
10.1016/j.ccell.2019.12.015

Entities

People

  • Andrew V Kossenkov
  • Bo Zhao
  • Galina Semenova
  • Jianhuang Lin
  • Mark E. Borowsky
  • Mark G. Cadungog
  • Nail Fatkhutdinov
  • Pyoung-hwa Park
  • Qin Liu
  • Rugang Zhang
  • Sergey Karakashev
  • Shuai Wu
  • Stephanie Jean
  • Takeshi Fukumoto

Organizations

  • American Association for Cancer Research
  • Congressionally Directed Medical Research Programs
  • National Cancer Institute